ABSTRACT
INTRODUCTION: The clinical course in patients with prostate cancer (PCa) after biochemical failure (BF) has received limited attention. This study analyzes survival time from recurrence, patterns of progression, and the efficacy of salvage therapies in patients treated with radical or postoperative radiotherapy (RT). METHODS: This is a multicenter retrospective comparative study of 1135 patients diagnosed with BF and treated with either radical (882) or postoperative (253) RT. Data correspond to the RECAP database. Clinical, tumor, and therapeutic characteristics were collected. Descriptive statistics, survival estimates, and comparisons of survival rates were calculated. RESULTS: Time to BF from initial treatment (RT or surgery) was higher in irradiated patients (51 vs 37 months). At a median follow-up of 102 months (14-254), the 8-year cause-specific survival (CSS) was 80.5%, without significant differences between the radical (80.1%) and postoperative (83.4%) RT groups. The 8-year metastasis-free survival rate was 57%. 173 patients (15%) died of PCa and 29 (2.5%) of a second cancer. No salvage therapy was given in 15% of pts. Only 5.5% of pts who underwent radical RT had local salvage treatment and 71% received androgen deprivation (AD) ± chemotherapy. The worst outcomes were in patients who developed metastases after BF (302 pts; 26.5%) and in cases with a Gleason > 7. CONCLUSIONS: In PCa treated with radiotherapy, median survival after BF is relatively long. In this sample, no differences in survival rates at 8-years have been found, regardless of the time of radiotherapy administered. AD was the most common treatment after BF. Metastases and high Gleason score are adverse variables. To our knowledge, this is the first study to compare outcomes after BF among patients treated with primary RT vs. those treated with postoperative RT and to evaluate recurrence patterns, treatments administered, and causes of death. The results allow avoiding overtreatment, improving quality of life, without negatively affecting survival.
Subject(s)
Brachytherapy/mortality , Databases, Factual , Neoplasm Recurrence, Local/mortality , Prostatic Neoplasms/mortality , Registries/statistics & numerical data , Adult , Aged , Aged, 80 and over , Follow-Up Studies , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/pathology , Neoplasm Recurrence, Local/radiotherapy , Prognosis , Prostatic Neoplasms/pathology , Prostatic Neoplasms/radiotherapy , Retrospective Studies , Survival RateABSTRACT
Weak radiative decays of the B mesons belong to the most important flavor changing processes that provide constraints on physics at the TeV scale. In the derivation of such constraints, accurate standard model predictions for the inclusive branching ratios play a crucial role. In the current Letter we present an update of these predictions, incorporating all our results for the O(α_{s}^{2}) and lower-order perturbative corrections that have been calculated after 2006. New estimates of nonperturbative effects are taken into account, too. For the CP- and isospin-averaged branching ratios, we find B_{sγ}=(3.36±0.23)×10^{-4} and B_{dγ}=(1.73_{-0.22}^{+0.12})×10^{-5}, for E_{γ}>1.6 GeV. Both results remain in agreement with the current experimental averages. Normalizing their sum to the inclusive semileptonic branching ratio, we obtain R_{γ}≡(B_{sγ}+B_{dγ})/B_{câν}=(3.31±0.22)×10^{-3}. A new bound from B_{sγ} on the charged Higgs boson mass in the two-Higgs-doublet-model II reads M_{H^{±}}>480 GeV at 95% C.L.
ABSTRACT
We present the calculation of the cross section for Higgs boson production in association with a top quark pair plus one jet, at next-to-leading-order accuracy in QCD. All mass dependence is retained without recurring to any approximation. After including the complete next-to-leading-order QCD corrections, we observe a strong reduction in the scale dependence of the result. We also show distributions for the invariant mass of the top quark pair, with and without the additional jet, and for the transverse momentum and the pseudorapidity of the Higgs boson. Results for the virtual contributions are obtained with a novel reduction approach based on integrand decomposition via the Laurent expansion, as implemented in the library, NINJA. Cross sections and differential distributions are obtained with an automated setup which combines the GOSAM and SHERPA frameworks.
ABSTRACT
We report on the calculation of the cross section for Higgs boson production in association with three jets via gluon fusion, at next-to-leading-order (NLO) accuracy in QCD, in the infinite top-mass approximation. After including the complete NLO QCD corrections, we observe a strong reduction in the scale dependence of the result, and an increased steepness in the transverse momentum distributions of both the Higgs boson and the leading jets. The results are obtained with the combined use of GOSAM, SHERPA, and the MADDIPOLE-MADEVENT framework.
Subject(s)
Abdominal Wall/diagnostic imaging , Colectomy , Laparotomy , Splenectomy , Surgical Wound Dehiscence/diagnostic imaging , Tomography, Emission-Computed , Adenocarcinoma/surgery , Anastomosis, Surgical , Colectomy/methods , Colonic Neoplasms/surgery , Humans , Male , Middle Aged , Postoperative PeriodABSTRACT
No disponible
No disponible
